QQ客服 官方微博 反馈留言

	Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study
	Zhai, Y.; Hui, Z.; Wang, J.; Zou, S.; Liang, J.; Wang, X.; Lv, J.; Chen, B.; Zhu, H.; Wang, L.
	2013
卷号	26期号:5页码:503-509
关键词	erlotinib esophageal cancer molecular targeted therapy radiotherapy squamous cell carcinoma
ISSN号	1120-8694
DOI	10.1111/j.1442-2050.2012.01380.x
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6705212
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhai, Y.,Hui, Z.,Wang, J.,et al. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study[J],2013,26(5):503-509.
APA	Zhai, Y..,Hui, Z..,Wang, J..,Zou, S..,Liang, J..,...&Wang, L..(2013).Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.,26(5),503-509.
MLA	Zhai, Y.,et al."Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study".26.5(2013):503-509.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。